Low Dose Psilocybin

DRUG4 trials

Sponsors

Yale University, Francisco A Moreno

Conditions

Major Depressive DisorderMigraine HeadacheObsessive - Compulsive DisorderPost-Traumatic Headache

Phase 1

Psilocybin for the Treatment of Migraine Headache

CompletedNCT03341689

Yale UniversityMigraine Headache

Start: 2017-11-01End: 2021-10-31Updated: 2023-10-12

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Active, not recruitingNCT03554174

Yale UniversityMajor Depressive Disorder

Start: 2018-02-27End: 2026-09-30Target: 18Updated: 2025-11-05

Effects of Psilocybin in Concussion Headache

TerminatedNCT03806985

Yale UniversityPost-Traumatic Headache

Start: 2019-03-28End: 2023-06-27Updated: 2023-10-12

Psilocybin for Treatment of OCD-2

Not yet recruitingNCT06992999

Francisco A MorenoObsessive - Compulsive Disorder

Start: 2026-09-08End: 2028-12-01Target: 20Updated: 2026-05-12

Related Papers

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

2020-11-1283 citations